Vaughan Nelson Investment Management, L.P. Abb Vie Inc. Transaction History

Vaughan Nelson Investment Management, L.P.

$10.6 Billion
Q3 2025

A detailed history of Vaughan Nelson Investment Management, L.P. transactions in Abb Vie Inc. stock. As of the latest transaction made, Vaughan Nelson Investment Management, L.P. holds 21,135 shares of ABBV stock, worth $4.89 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

21,135

Previous 21,135 -0.0%

Holding current value

$4.89 Million

Previous $3.92 Million 24.73%

% of portfolio

0.05%

Previous 0.04%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$163.84 - $199.33 $9,830 - $11,959	60 Added 0.28%	21,135 $4.17 Million
Q1 2024 Apr 18, 2024	SELL	$159.82 - $182.1 $4,315 - $4,916	-27 Reduced 0.13%	21,075 $3.84 Million
Q4 2023 Jan 24, 2024	SELL	$137.6 - $154.97 $409,084 - $460,725	-2,973 Reduced 12.35%	21,102 $3.27 Million
Q3 2023 Nov 09, 2023	BUY	$133.59 - $154.65 $22,042 - $25,517	165 Added 0.69%	24,075 $3.59 Million
Q2 2023 Aug 03, 2023	SELL	$132.51 - $164.9 $267,007 - $332,273	-2,015 Reduced 7.77%	23,910 $3.22 Million
Q1 2023 May 05, 2023	SELL	$144.61 - $166.54 $1.3 Million - $1.5 Million	-9,000 Reduced 25.77%	25,925 $4.13 Million
Q4 2022 Jan 30, 2023	BUY	$138.31 - $165.87 $103,732 - $124,402	750 Added 2.19%	34,925 $5.64 Million
Q4 2021 Jan 13, 2022	SELL	$107.43 - $135.93 $142,559 - $180,379	-1,327 Reduced 3.74%	34,175 $4.63 Million
Q3 2021 Oct 27, 2021	BUY	$106.4 - $120.78 $476,352 - $540,732	4,477 Added 14.43%	35,502 $3.83 Million
Q2 2021 Jul 15, 2021	BUY	$105.21 - $117.21 $276,176 - $307,676	2,625 Added 9.24%	31,025 $3.5 Million
Q1 2021 May 11, 2021	BUY	$102.3 - $112.62 $434,775 - $478,635	4,250 Added 17.6%	28,400 $3.07 Million
Q4 2020 Feb 04, 2021	BUY	$80.49 - $108.67 $998,075 - $1.35 Million	12,400 Added 105.53%	24,150 $2.59 Million
Q3 2020 Nov 09, 2020	SELL	$85.91 - $100.83 $57.8 Million - $67.8 Million	-672,620 Reduced 98.28%	11,750 $1.03 Million
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $1.52 Million - $2.03 Million	-20,695 Reduced 2.94%	684,370 $67.2 Million
Q1 2020 May 14, 2020	SELL	$64.5 - $97.79 $65.9 Million - $99.9 Million	-1,021,180 Reduced 59.16%	705,065 $53.7 Million
Q4 2019 Feb 05, 2020	BUY	$72.13 - $90.25 $497,336 - $622,273	6,895 Added 0.4%	1,726,245 $153 Million
Q3 2019 Nov 06, 2019	BUY	$62.98 - $75.72 $15 Million - $18.1 Million	238,535 Added 16.11%	1,719,350 $130 Million
Q2 2019 Aug 09, 2019	BUY	$65.7 - $83.98 $26.6 Million - $34 Million	404,500 Added 37.58%	1,480,815 $108 Million
Q1 2019 May 13, 2019	BUY	$77.14 - $90.79 $1.07 Million - $1.26 Million	13,865 Added 1.31%	1,076,315 $86.7 Million
Q4 2018 Jan 30, 2019	BUY	$77.85 - $96.01 $82.7 Million - $102 Million	1,062,450 New	1,062,450 $97.9 Million

Others Institutions Holding ABBV

# of Institutions

4,350

Shares Held

1.3B

Call Options Held

16.1M

Put Options Held

10.9M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $409B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vaughan Nelson Investment Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Vaughan Nelson Investment Management, L.P. with notifications on news.

Account

Vaughan Nelson Investment Management, L.P. Abb Vie Inc. Transaction History